日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome

荧光素血管造影作为苏萨克综合征疾病活动性的替代标志物

期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.5
doi:10.1212/NXI.0000000000200379
Guttieres, Laura; Vannelli, Lea; Demortiere, Sarah; Perriguey, Marine; Elziere, Maya; Durozard, Pierre; Boutiere, Clemence; Rico, Audrey; Hilezian, Frederic; Stellmann, Jan-Patrick; Pelletier, Jean; Maarouf, Adil; Stolowy, Natacha; Audoin, Bertrand
IF
发表日期：2025
文献求助 收藏

Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis

Kappa游离轻链指数在成人首发性视神经炎诊断中的应用价值

期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.5
doi:10.1212/NXI.0000000000200386
Demortiere, Sarah; Stolowy, Natacha; Perriguey, Marine; Boutiere, Clemence; Rico, Audrey; Hilezian, Frederic; Ndjomo-Ndjomo, Blaise-Roger; Durozard, Pierre; Stellmann, Jan-Patrick; Marignier, Romain; Boucraut, José; Pelletier, Jean; Maarouf, Adil; Audoin, Bertrand
发表日期：2025
文献求助 收藏

Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis

延长利妥昔单抗/奥瑞珠单抗给药间隔与多发性硬化症中IgG水平下降减少相关

期刊:Neurotherapeutics
影响因子:6.9
doi:10.1016/j.neurot.2025.e00554
Rigollet, Camille; Freeman, Sean A; Perriguey, Marine; Stellmann, Jan-Patrick; Graille-Avy, Lisa; Lafontaine, Jean-Christophe; Lemarchant, Bruno; Alberto, Tifanie; Demortière, Sarah; Boutiere, Clémence; Rico, Audrey; Hilézian, Frédéric; Durozard, Pierre; Pelletier, Jean; Maarouf, Adil; Zéphir, Hélène; Audoin, Bertrand
神经科学
IgG
多发性硬化症
发表日期：2025
文献求助 收藏

Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis

非抗CD20疗法后低丙种球蛋白血症的患病率以及在多发性硬化症中改用利妥昔单抗/奥瑞珠单抗的影响

期刊:Neurotherapeutics
影响因子:6.9
doi:10.1016/j.neurot.2025.e00760
Perriguey, Marine; Rigollet, Camille; Freeman, Sean A; Graille-Avy, Lisa; Lafontaine, Jean-Christophe; Lemarchant, Bruno; Alberto, Tifanie; Demortière, Sarah; Boutiere, Clémence; Rico, Audrey; Hilézian, Frédéric; Durozard, Pierre; Pelletier, Jean; Maarouf, Adil; Zéphir, Hélène; Audoin, Bertrand
神经科学
CD20
CD2
多发性硬化症
发表日期：2025
文献求助 收藏

Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis

芬戈莫德既往治疗对多发性硬化症患者利妥昔单抗/奥瑞珠单抗早期和晚期疗效的影响

期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.5
doi:10.1212/NXI.0000000000200231
Graille-Avy, Lisa; Boutiere, Clemence; Rigollet, Camille; Perriguey, Marine; Rico, Audrey; Demortiere, Sarah; Durozard, Pierre; Hilezian, Frederic; Vely, Frederic; Bertault-Peres, Pierre; Pelletier, Jean; Maarouf, Adil; Audoin, Bertrand
神经科学
多发性硬化症
发表日期：2024
文献求助 收藏

Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?

利妥昔单抗在多发性硬化症中的疗效持续时间超过 B 细胞再生：是时候重新考虑给药方案了吗？

期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.5
doi:10.1212/NXI.0000000000200152
Claverie, Roxane; Perriguey, Marine; Rico, Audrey; Boutiere, Clemence; Demortiere, Sarah; Durozard, Pierre; Hilezian, Frederic; Dubrou, Clea; Vely, Frederic; Pelletier, Jean; Audoin, Bertrand; Maarouf, Adil
神经科学
细胞生物学
T细胞
多发性硬化症
发表日期：2023
文献求助 收藏

Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab

利妥昔单抗治疗多发性硬化症患者的低丙种球蛋白血症和感染

期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.5
doi:10.1212/NXI.0000000000001115
Perriguey, Marine; Maarouf, Adil; Stellmann, Jan-Patrick; Rico, Audrey; Boutiere, Clemence; Demortiere, Sarah; Durozard, Pierre; Pelletier, Jean; Audoin, Bertrand
炎症/感染
神经科学
多发性硬化症
发表日期：2022
文献求助 收藏

Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?

在新冠肺炎疫情期间及之后，是否应该延长多发性硬化症患者的利妥昔单抗给药间隔？

期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.5
doi:10.1212/NXI.0000000000000825
Maarouf, Adil; Rico, Audrey; Boutiere, Clemence; Perriguey, Marine; Demortiere, Sarah; Pelletier, Jean; Audoin, Bertrand
肺炎
新冠
神经科学
多发性硬化症
微生物学
发表日期：2020
文献求助 收藏